BioSpace News Archive

WSHA joins 25 other state associations in judicial advocacy on behalf of the Affordable Care Act

Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today announced that Brazil’s National Health Surveillance Agency (ANVISA), Japan’s Pharmaceuticals and Medical Device Agency (PMDA), and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) are increasing their adoption of Certara’s Phoenix® software to evaluate drug regulatory submissions.

Sobi announced that investigators will present data from across its rare disease and specialty care portfolio at multiple scientific meetings this Spring.

Continued support of existing investors will fund commercialization efforts, product launch later this year

Shionogi & Co., Ltd. and its European subsidiary, Shionogi B.V., announced it will present four posters on lusutrombopag, a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist, at The International Liver Congress™, the annual meeting of the European Association for the Study of the Liver (EASL), to be held in Vienna, Austria, April 10-14, 2019.

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and LakePharma, Inc., the leading US-based biologics CRDMO, today announced a strategic collaboration to offer antibody discovery and development solutions to pharmaceutical and biotechnology customers.

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced that the Company completed an at-the-market offering for $5.3 million in gross proceeds, with insiders responsible for supporting over 37% of the raise.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is proud to join the LGBTQ community in celebrating the 2019 LGBTQ Pride season through its participation in 24 Pride events across the country—in many locations, touring with its “Our Champions” Pride bus.

DocuSol® Kids mini-enemas are often used by parents dealing with children who routinely avoid using the bathroom and become constipated.

Puma Biotechnology, Inc., a biopharmaceutical company, has expanded two additional cohorts from the Phase II SUMMIT clinical trial investigating its lead drug candidate neratinib in patients with solid tumors who have an activating EGFR or HER2 mutation.